PMN: ProMIS Neurosciences, Inc. Stock

by  •  • Comments Off on PMN: ProMIS Neurosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 37.92
Enterprise Value ($M) 25.32
Book Value ($M) 3.75
Book Value / Share 0.20
Price / Book 10.10
NCAV ($M) 3.75
NCAV / Share 0.20
Price / NCAV 10.10

Profitability (mra)
Return on Invested Capital (ROIC) -3.52
Return on Assets (ROA) -2.98
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.46
Current Ratio 1.46

Balance Sheet (mrq) ($M)
Current Assets 13.62
Assets 13.62
Liabilities 9.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.46
Net Income -13.21

Cash Flow Statement (mra) ($M)
Cash From Operations -10.84
Cash from Investing -0.00
Cash from Financing 17.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G/A Sphera Funds Management Ltd. 9.99 2.16
01-02 13G/A Sclar Jeremy M. 17.40
12-27 13G/A Gordon Michael S 12.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 699 1,417 49.33
2024-05-13 170 2,812 6.05
2024-05-10 1,409 1,661 84.83
2024-05-09 988 1,740 56.78

(click for more detail)

Similar Companies
PIRS – Pieris Pharmaceuticals, Inc. PLUR – Pluri Inc.
PMCB – PharmaCyte Biotech, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp.


Financial data and stock pages provided by
Fintel.io